Aryan Mishra: β-Thalassemia Analyzer: HPLC for Hemoglobinopathy Screening
Aryan Mishra, Sales Executive at Surana Enterprises, shared a post on LinkedIn:
“β-Thalassemia Analyzer: What Does It Actually Do?
A routine CBC can provide important clues, but evaluating β-thalassemia and other hemoglobinopathies may require detailed hemoglobin analysis.
Many dedicated systems use HPLC (High-Performance Liquid Chromatography) to separate and quantify different hemoglobin fractions.
Blood Sample leads to Separation, followed by Detection, Chromatogram, and Result.
Key parameters such as HbA₂ and HbF can provide valuable information during laboratory evaluation.
Why is this technology important?
- Carrier screening
- HbA₂ & HbF quantification
- Hemoglobin variant analysis
- Hemoglobinopathy screening
- Standardized laboratory workflow
Key takeaway: A diagnostic analyzer isn’t just a machine—it is a tool that helps laboratories generate clinically meaningful information.”
Stay updated with Hemostasis Today.
-
Sep 7, 2026, 09:04Daniel Pereira Monteiro: Haemopaedia Case of the Week – Hemoglobinopathy Diagnosis and Confirmatory Testing
-
Sep 7, 2026, 08:51Judith de Vos: The Immune Composition of Thrombi in Ischemic Stroke
-
Sep 7, 2026, 08:50Maria Cherska: Lipid Metabolism and Immune Remodeling in Metastatic Colorectal Cancer
-
Sep 7, 2026, 08:28Deanna Joseph: Exploring Factor XIII Deficiency Through Summer Research
-
Sep 7, 2026, 08:17Nasim Hosseini: Women’s Blood Donation and the Social Determinants of Health
-
Sep 7, 2026, 08:12David McIntosh: The Global Plasma Supply Debate
-
Sep 7, 2026, 08:03Julio Avella: Advancing IDA Care Through Scientific Education and Collaboration
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment